Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,876–5,900 of 7,816 matching trials · page 236 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Effect of an Intervention Based on Implicit Theories of Personality on the Prevention of Adolescent Dating Violence NCT03583645 Incremental theory of personality; Educational Intervention |
NA other |
COMPLETED | 402 | University of Deusto OTHER |
2018-11-09 |
|
[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002) NCT01385033 [18F]MK-3328 |
PHASE1 other |
TERMINATED | 20 | Merck Sharp & Dohme LLC INDUSTRY |
2018-11-08 |
|
A Multiple Ascending Dose Study of COR388 NCT03418688 COR388; Placebo Runs in: United States · 3 sites |
PHASE1 other |
COMPLETED | 33 | Cortexyme Inc. INDUSTRY |
2018-11-07 |
|
Maximizing Independence at Home (MIND at Home) NCT01283750 care coordination Runs in: United States · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 303 | Johns Hopkins University OTHER |
2018-11-06 |
|
MindMate: A Study of a Reminder System for People With Dementia NCT02908997 MindMate Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 3 | NHS Greater Glasgow and Clyde OTHER |
2018-11-06 |
|
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease- NCT01129596 donepezil hydrochloride Runs in: Japan · 722 sites |
NA symptomatic-cholinergic |
COMPLETED | 10,238 | Eisai Co., Ltd. INDUSTRY |
2018-11-05 |
|
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD NCT02681172 Neuraceq (florbetaben 18F); PET Runs in: France · 1 site |
PHASE4 other |
COMPLETED | 218 | Piramal Imaging Limited INDUSTRY |
2018-11-02 |
|
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease NCT03316898 AGN-242071; Placebo; Donepezil; Memantine Runs in: United States · 6 sites |
PHASE1 symptomatic-cholinergic |
WITHDRAWN | 0 | Allergan INDUSTRY |
2018-11-02 |
|
First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979 NCT02509117 PF-06751979 single ascending dose; Placebo single dose; PF-06751979... Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 55 | Pfizer INDUSTRY |
2018-11-01 |
|
A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma NCT00038545 Filgrastim SD/01; Paclitaxel; Topotecan Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 25 | M.D. Anderson Cancer Center OTHER |
2018-10-30 |
|
Correlation Study Between Mental Behavioral Symptoms in Dementia Patients and Mood Disorders of Caregivers NCT03724344 Cross section resaerch Runs in: China · 1 site |
NA other |
UNKNOWN | 100 | Shanghai Mental Health Center OTHER |
2018-10-30 |
|
Oxidative Stress and Nutritional Supplementation Intervention Study NCT01234506 secoisolariciresinol diglucoside Runs in: Canada · 1 site |
PHASE2 other |
COMPLETED | 21 | University of Saskatchewan OTHER |
2018-10-25 |
|
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) NCT01739348 Verubecestat (Part I and Part II); Verubecestat (Part I and Part II... |
PHASE2|PHASE3 BACE-inhibitor |
TERMINATED | 2,211 | Merck Sharp & Dohme LLC INDUSTRY |
2018-10-24 |
|
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials NCT02918539 florbetapir F 18 PET scan Runs in: United States · 75 sites |
NA other |
COMPLETED | 317 | Avid Radiopharmaceuticals INDUSTRY |
2018-10-24 |
|
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease NCT00462917 Pleiotropic info, in-person disclosure; AD-only info, in-person dis... Runs in: United States · 4 sites |
NA other |
COMPLETED | 290 | Brigham and Women's Hospital OTHER |
2018-10-23 |
|
The Effects of a Walking Program on Balance, Falls and Well Being in Individuals Residing in Long-term Care NCT01277809 Interpersonal Interaction; Walking Program Runs in: Canada · 1 site |
NA other |
COMPLETED | 179 | University of Saskatchewan OTHER |
2018-10-23 |
|
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV NCT01434667 APOE genotype and Alzheimer's disease risk disclosure; Alzheimer's ... Runs in: United States · 3 sites |
NA other |
COMPLETED | 146 | Brigham and Women's Hospital OTHER |
2018-10-23 |
|
Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia NCT01761227 Fufangdanshen Tablets; Placebo Runs in: China · 1 site |
PHASE2 other |
COMPLETED | 240 | Dongzhimen Hospital, Beijing OTHER |
2018-10-23 |
|
Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment NCT02982603 Qinggongshoutao Bolus; Ginkgo Biloba Extract 761; Placebos Runs in: China · 1 site |
PHASE4 other |
COMPLETED | 350 | Dongzhimen Hospital, Beijing OTHER |
2018-10-23 |
|
Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease NCT02074410 OMS643762; Placebo Runs in: United States · 9 sites |
PHASE2 other |
TERMINATED | 22 | Omeros Corporation INDUSTRY |
2018-10-22 |
|
NP001, Alzheimer's Disease, and Blood Markers of Inflammation NCT03179501 NP001; Placebo Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 4 | Beau Nakamoto OTHER |
2018-10-22 |
|
Autologous Stem/Stromal Cells in Neurological Disorders and Disease NCT03297177 Microcannula Harvest Adipose; Centricyte 1000; Sterile Normal Salin... Runs in: United States · 2 sites |
NA other |
UNKNOWN | 300 | Regeneris Medical OTHER |
2018-10-18 |
|
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) NCT00874939 MK-0249 7.5 mg; MK-0249 25 mg; Donepezil 5mg; Placebo to MK-0249; P... |
PHASE1 symptomatic-cholinergic |
TERMINATED | 4 | Merck Sharp & Dohme LLC INDUSTRY |
2018-10-17 |
|
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects NCT00827034 Warfarin; Dimebon; Warfarin Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 14 | Pfizer INDUSTRY |
2018-10-16 |
|
Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease NCT02708485 Physical exercise Runs in: Canada · 1 site |
NA other |
COMPLETED | 15 | Université de Sherbrooke OTHER |
2018-10-16 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial